Henrijette Richter
InvestorManaging Partner at Sofinnova Partners · Managing Partner at Sofinnovapartners
Paris, France
Writes $100K – $5M checks · typically $1.5M
Find your path to Henrijette
459 people in our graph share verified history with Henrijette — schools, employers, funds. One of them is your warm intro.
Kyle DohertyunlockedHenrijette: together at Harvard Business School (2008)
×10Henrijette: together at Harvard Business School
Henrijette: together at Nitrase Therapeutics
About
Managing Partner at Sofinnova Partners and member of the Sofinnova Capital Strategy team, its early-stage biotech and medtech fund. She joined in 2014 and has led life science investments including HAYA Therapeutics, Muna Therapeutics, NodThera, and Delinia (acquired by Celgene). Previously she helped build Novo Seeds from its 2007 founding and began her venture career at Sunstone Capital.
Contact· published on Henrijette's own website
Invests in
BiotechMedical Devices
Managing Partner at Sofinnovapartners
Intro paths
→
In turn, Henrijette can intro founders to Sofinnovapartners's investors below.
Sofinnovapartners's investors · 2
Experience
- Sofinnova PartnersManaging Partnercurrent2017 — presentParis Area, France
- Sofinnova PartnersPartner2014 — 2017Paris Area, France
- Mozart Therapeutics, IncBoard Membercurrent2021 — presentSeattle, Washington, United States
- Nitrase TherapeuticsBoard Membercurrent2020 — presentSan Francisco, California, United States
- Nitrase TherapeuticsBoard Membercurrent2020 — presentSan Francisco, California, United States
- Muna TherapeuticsBoard Membercurrent2021 — presentCopenhagen, Capital Region, Denmark
- Muna TherapeuticsBoard Membercurrent2021 — presentCopenhagen, Capital Region, Denmark
- Twentyeight-Seven TherapeuticsBoard Membercurrent2019 — presentWatertown, Massachusetts, United States
- Twentyeight-Seven TherapeuticsBoard Membercurrent2019 — presentWatertown, Massachusetts, United States
Skills & more
Investments12Finance5
Languages English
From Henrijette's professional profile.
Investments
Investor
Avilex PharmaDeliniaEpiTherapeuticsFreya BiosciencesHaya TherapeuticsMozart TherapeuticsMuna TherapeuticsNanoPhoria BioscienceNodtheraOrphazyme
Per the firm's website.
Colleagues at Sofinnova Partners
Agnès Pauquet
Head of Human Resources at Sofinnova Partners
Ahmed Fourati
Investor Relations and Reporting Officer at Sofinnova Partners
Aishwarya Parthasarathy
Associate, Digital Medicine Strategy at Sofinnova Partners
Alex Leech
Partner, Biovelocita Strategy at Sofinnova Partners
Alexandra Abreu
Analyst, Crossover Strategy at Sofinnova Partners
Andy Weiss
Operating Advisor at Sonder Capital
Anis Belmili
Fund Accountant at Sofinnova Partners
Ankeet Jethwa
Senior Associate, Capital Strategy at Sofinnova Partners
Network1
Investors connected to Henrijette in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Henrijette Richter?
- Managing Partner at Sofinnova Partners and member of the Sofinnova Capital Strategy team, its early-stage biotech and medtech fund. She joined in 2014 and has led life science investments including HAYA Therapeutics, Muna Therapeutics, NodThera, and Delinia (acquired by Celgene). Previously she helped build Novo Seeds from its 2007 founding and began her venture career at Sunstone Capital.
- Where does Henrijette Richter work?
- Henrijette Richter is Managing Partner at Sofinnova Partners and Managing Partner at Sofinnovapartners.
- What does Henrijette Richter invest in?
- Henrijette Richter invests in Biotech, Medical Devices.
- What check size does Henrijette Richter write?
- Henrijette Richter typically writes checks of $100K – $5M.
- What companies has Henrijette Richter invested in?
- Investments tracked here include Avilex Pharma, Delinia, EpiTherapeutics, Freya Biosciences, Haya Therapeutics, Mozart Therapeutics, Muna Therapeutics, NanoPhoria Bioscience, Nodthera, Orphazyme.
- Where did Henrijette Richter go to school?
- Henrijette Richter studied at Harvard Business School (executive course, Venture Capital and Private Equity); Copenhagen Business School (Executive Certificate, Business Administration with focus on Leadership and Business Essentials).
Same school
Also attended Harvard Business School2,000
Aileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalMike Maples JrCo-founding Partner at FloodgateNeeraj AgrawalGeneral Partner at Battery VenturesHristo BorisovCo-founder & CEO of PayhawkVictoria TreygerGeneral Partner at Felicis Ventures
+ 1,994 more
Also attended Copenhagen Business School532
Jeppe RindomCo-founder & CEO of PleoLinaInvestor at InvestinorJonathan W.Deeptech Fellow at Clear VenturesThanachat Tangsriwongタイオフィス代表 (Thailand Office Representative) at CyberAgent CapitalAntonio GrifoniAssociate at P101 VenturesThomas JuvinManaging Director Europe at Burda Principal Investments
+ 526 more
Shared employers
Also worked at Sofinnova Partners78
Anne HorganPartner at Cambridge Innovation CapitalLaetitia SchwabPrincipal at SR One Capital ManagementAntoine Papiernik PapiernikChairman and Managing Partner at Sofinnova PartnersGraziano SeghezziManaging Partner at Sofinnova PartnersMichael KrelPartner at Sofinnova PartnersZhizhong YaoPartner at Sofinnova Partners
+ 72 more
Also worked at Mozart Therapeutics, Inc5
Also worked at Nitrase Therapeutics8
Robert BlazejPartner at Mission BiocapitalMiles GersonPartner at Dementia Discovery FundAnta GkelouPartner, Capital Strategy at Sofinnova PartnersShawna FrazierDirector at AbbVieJonathan BehrPartner at SV Health InvestorsDirk LandgrafPrincipal at SV Health Investors
+ 2 more
Also worked at Muna Therapeutics8
Christina TakkeManaging Partner at V-Bio VenturesCamilla Petrycer HansenPartner at Novo HoldingsCillian KingManaging Director at EQT Life SciencesRita Balice-GordonFounder at Muna TherapeuticsMichel DetheuxChairman at Egle TxOttavio V. VitoloChief Medical Officer at Cerevance
+ 2 more